This lecture outlines the current pharmacological concepts of sedation
and analgesia in the critically ill patient requiring intensive care
therapy. The primary goal is to sedate such patients so that they tole
rate mechanical ventilation, as well as the therapeutic and diagnostic
procedures that are routinely performed on an intensive care ward. Th
e pharmacological regimen comprises both anxiolytic and analgesic drug
s. So far, no drug combination has been identified as the ideal therap
y; the standard deviation of successful analgosedation is large due to
an unpredictable individual response. Because the drugs currently use
d are free of toxic side effects, the selection made is mainly determi
ned by factors relating to pharmacokinetic criteria, such as short hal
f-life of action or a predictable time of elimination. So far, the sel
ection or combination of certain drugs has not been found to influence
the patient's outcome in severe disease states such as sepsis, multip
le trauma, or neurotrauma. ''Good quality'' of sedation and analgesia
is still judged by its ability to suppress tachycardia, hypertension,
hyperventilation or respiratory efforts against mechanical ventilation
and the absence of increases in intracranial pressure during therapeu
tic manoeuvres.